These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 38177

  • 1. National Cooperative Crohn's Disease Study: adverse reactions to study drugs.
    Singleton JW, Law DH, Kelley ML, Mekhjian HS, Sturdevant RA.
    Gastroenterology; 1979 Oct; 77(4 Pt 2):870-82. PubMed ID: 38177
    [Abstract] [Full Text] [Related]

  • 2. Azathioprine-related pancreatitis in patients with Crohn's disease.
    Sturdevant RA, Singleton JW, Deren JL, Law DH, McCleery JL.
    Gastroenterology; 1979 Oct; 77(4 Pt 2):883-6. PubMed ID: 38178
    [Abstract] [Full Text] [Related]

  • 3. National Cooperative Crohn's Disease Study: results of drug treatment.
    Summers RW, Switz DM, Sessions JT, Becktel JM, Best WR, Kern F, Singleton JW.
    Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
    [Abstract] [Full Text] [Related]

  • 4. National Cooperative Crohn's Disease Study: study design and conduct of the study.
    Winship DH, Summers RW, Singleton JW, Best WR, Becktel JM, Lenk LF, Kern F.
    Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
    [Abstract] [Full Text] [Related]

  • 5. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
    Singleton JW, Summers RW, Kern F, Becktel JM, Best WR, Hansen RN, Winship DH.
    Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B, Alm T, Bárány F, Bergelin I, Ganrot-Norlin K, Hoevels J, Huitfeldt B, Järnerot G, Krause U, Krook A, Lindström B, Nordle O, Rosén A.
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [Abstract] [Full Text] [Related]

  • 7. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 8. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI, Present DH.
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract] [Full Text] [Related]

  • 9. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
    Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, Jesdinsky H.
    Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 11. How should we treat Crohn's disease?
    Sleisenger MH.
    N Engl J Med; 1980 May 01; 302(18):1024-6. PubMed ID: 6102738
    [No Abstract] [Full Text] [Related]

  • 12. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb 01; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 13. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
    Singleton JW.
    Z Gastroenterol Verh; 1981 Jun 01; 19():38-40. PubMed ID: 6168133
    [No Abstract] [Full Text] [Related]

  • 14. The National Cooperative Crohn's Disease Study.
    MacLean LD.
    Can J Surg; 1980 Jan 01; 23(1):7-8. PubMed ID: 6102492
    [No Abstract] [Full Text] [Related]

  • 15. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
    Bajaj JS, Saeian K, Varma RR, Franco J, Knox JF, Podoll J, Emmons J, Levy M, Binion DG.
    Am J Gastroenterol; 2005 May 01; 100(5):1121-5. PubMed ID: 15842588
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
    Rosén A, Ursing B, Alm T, Bárány F, Bergelin I, Ganrot-Norlin K, Hoevels J, Huitfeldt B, Järnerot G, Krause U, Krook A, Lindström B, Nordle O.
    Gastroenterology; 1982 Sep 01; 83(3):541-9. PubMed ID: 6124473
    [Abstract] [Full Text] [Related]

  • 17. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C, Scribano ML.
    Ital J Gastroenterol Hepatol; 1999 Sep 01; 31(6):515-8. PubMed ID: 10575572
    [Abstract] [Full Text] [Related]

  • 18. Correlations between clinical, blood leukocyte, and skin test data in the National Cooperative Crohn's Disease Study.
    Beeken WL, Sessions JT, Bozymski EM.
    Gastroenterology; 1979 Oct 01; 77(4 Pt 2):921-4. PubMed ID: 38180
    [Abstract] [Full Text] [Related]

  • 19. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
    Lémann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF, Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID).
    Gastroenterology; 2006 Apr 01; 130(4):1054-61. PubMed ID: 16618399
    [Abstract] [Full Text] [Related]

  • 20. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
    Weersma RK, Peters FT, Oostenbrug LE, van den Berg AP, van Haastert M, Ploeg RJ, Posthumus MD, Homan van der Heide JJ, Jansen PL, van Dullemen HM.
    Aliment Pharmacol Ther; 2004 Oct 15; 20(8):843-50. PubMed ID: 15479355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.